Nutrition assessment in HIV infection

Nutrition in Clinical Care

Volumn 8, Issue 1, 2005, Pages 6-15

  Gerrior, Jül L ^a   Neff, Lisa M ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

HAART; Highly active anti retroviral therapy; HIV; Hypertriglyceridemia; Nutrition

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CYANOCOBALAMIN; DRONABINOL; ERGOCALCIFEROL; FOLIC ACID; GLUTAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NANDROLONE; NICOTINIC ACID; OXANDROLONE; PROBIOTIC AGENT; PYRIDOXINE; RETINOL; RIBOFLAVIN; SELENIUM; THIAMINE; TRACE ELEMENT; VITAMIN; VITAMIN D; VITAMIN K GROUP; ZINC; LIPID;

ANOREXIA; ANTHROPOMETRY; BERIBERI; BODY BUILD; BODY WEIGHT; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DIARRHEA; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE PREDISPOSITION; DYSLIPIDEMIA; EDEMA; EXERCISE; GLUCOSE TOLERANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOGONADISM; INSULIN RESISTANCE; KWASHIORKOR; LABORATORY TEST; LIPID STORAGE; LIPODYSTROPHY; LIVER DYSFUNCTION; LONG TERM CARE; MARASMUS; MENTAL DISEASE; NEUROLOGIC DISEASE; NUTRITION; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; OBESITY; PATIENT CARE; PATIENT COUNSELING; PELLAGRA; PHYSICAL EXAMINATION; PROTEIN DIET; QUALITY OF LIFE; REVIEW; SCURVY; SKINFOLD THICKNESS; SYMPTOM; VITAMIN DEFICIENCY; WASTING SYNDROME; WEIGHT GAIN; WEIGHT REDUCTION; BLOOD; NUTRITIONAL ASSESSMENT;

HUMAN IMMUNODEFICIENCY VIRUS;

ANTHROPOMETRY; DIARRHEA; DIETARY SUPPLEMENTS; HIV INFECTIONS; HUMANS; LIPIDS; MICRONUTRIENTS; NUTRITION ASSESSMENT; WEIGHT LOSS;

EID: 24044443965     PISSN: 10966781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals infected with HIV in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;31:803-805.
2. Kotler DP. Nutritional effects and support in the patient with acquired immunodeficiency syndrome. J Nutr. 1992;122:(suppl 3):723-727.
3. Wanke CA, Falutz J, Shevitz A, Phair JP, Kotler DP. Clinical evaluation and management of metabolic and morphologic abnormalities associated with HIV. Clin Infect Dis. 2002;34:248-259.
4. Bell SJ, Mascioli EA, Forse RA, Bistrian BR. Nutrition support and the human immunodeficiency virus (HIV). Parasitology. 1993;107(suppl):S53-S67.
5. Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E, Gorbach SL. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:230-236.
6. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr. 1998;18:80-85.
7. Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. J Parenter Enteral Nutr. 1977;1:11-22.
8. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-447.
9. Gerrior J, Wanke C. Nutrition and Acquired Immunodeficiency Syndrome (AIDS). In: Coulston AM, Rock C, Monsen E, eds. Nutrition in the Prevention and Treatment of Disease. San Diego: Academic Press; 2001.
10. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353:2093-2099.
11. Dube MP, Sprecher D, Henry WK, et al.; Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Preliminary guidelines for the evaluation and management of dyslipidemia in HIV-infected adults receiving antiretroviral therapy. Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Clin Infect Dis. 2000;31:1216-1224.
12. Liang B, Chung S, Araghiniknam M, Lane LC, Watson RR. Vitamins and immunomodulation in AIDS. Nutrition. 1996;12:1-7.
13. Muri RM, Von Overbeck J, Furrer J, Ballmer PE. Thiamin deficiency in HIV-positive patients: evaluation by erythrocyte transketolase activity and thiamin pyrophosphate effect. Clin Nutr. 1999;18:375-378.
14. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51-F58.
15. Fields-Gardner C, Ayoob KT. Position of the American Dietetic Association and Dietitians of Canada: Nutrition intervention in the care of persons with human immunodeficiency virus infection. J Am Diet Assoc. 2000;100:708-717.
16. McDermott A, Shevitz A, Must A, Harris S, Roubenoff R, Gorbach SL. Nutrition treatment for HIV wasting: A prescription for food as medicine. Nutrition in Clinical Practice. 2003;18:86-96.
17. Stack JA, Bell SJ, Burke PA, Forse RA. High-energy, high-protein, oral, liquid, nutrition supplementation in patients with HIV infection: effect on weight status in relation to incidence of secondary infection. J Am Diet Assoc. 1996;96:337-341.
18. Sheehan LA, Macallan DC. Determinants of energy intake and energy expenditure in HIV and AIDS. Nutrition. 2000;16:101-106.
19. Grinspoon S, Mulligan K; Department of Health and Human Services Working Group on the Prevention and Treatment of Wasting and Weight Loss. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis. 2003:36(suppl 2):S69-S78.
20. Roubenoff R, McDermott A, Weiss L, et al. Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus. AIDS. 1999;13:231-9.
21. Grinspoon S, Corcoran C, Parlman K, et al. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting: a randomized, controlled trial. Ann Intern Med. 2000;133:348-355.
22. Schambelan M, Mulligan K, Grunfeld C, et al. Recombinant human growth hormone in patients with HIV-associated wasting: a randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med. 1996;125:873-882
23. Bhasin S, Storer TW, Asbel-Sethi N, et al. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency-virus infected men with low testosterone levels. J Clin Endocrinol Metab. 1998;83:3155-3162.
24. Grinspoon S, Corcoran C, Askari H, et al. Effects of androgen administration in men with the AIDS wasting syndrome: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;129:18-26.
25. Reyes-Teran G, Sierra-Madero JG, Martinez del Cerro V, et al. Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial. AIDS. 1996;10:1501-1507.
26. Klausner JD, Makonkawkeyoon S, Akarasewi P, et al. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:247-257.
27. Kaplan G, Thomas S, Fierer DS, et al. Thalidomide for the treatment of AIDS-associated wasting. AIDS Res Hum Retroviruses. 2000;16:1345-1355.
28. Wanke CA, Silva M, Ganda A, et al. Role of acquired immune deficiency syndrome-defining conditions in human immunodeficiency virus-associated wasting. Clin Infect Dis. 2003;37:S81-S84
29. Knox TA, Spiegelman D, Skinner SC, Gorbach SL. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol. 2000;95:3482-3489.
30. Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men. J Acquir Immune Defic Syndr. 1993;6:949-958.
31. Tang AM, Graham NM, Kirby AJ, McCall LD, Willett WC, Saah AJ. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol. 1993;138:937-951.
32. Fawzi WW, Msamanga GI, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. New Engl J Med. 2004;351:23-32.
33. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
34. Yarasheski KE, Tebas P, Stanerson B, et al. Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy. J Appl Physiol. 2001;90:133-138.
35. Shor-Posner G, Campa A, Zhang G, et al. When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr. 2000;23:81-88.